Related Experiment Video
Updated: May 19, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Bringing Risk-Based Auditing to 503A Pharmacy Accreditation
1Coalition for Compounding Excellence, Loveland, CO, USA. lrd@cce-team.com.
None:
Compounding pharmacies operate in a complex regulatory environment where not all deficiencies carry equal consequences. Traditional checklist-based inspections are effective at verifying compliance with published standards, but they often fail to distinguish minor documentation lapses from conditions that pose significant risk to patients, staff, or the viability of the pharmacy itself. Risk-based auditing offers a more targeted, defensible approach, one that aligns inspection effort with the severity and likelihood of harm. This article explores how risk-based auditing principles can be applied to 503A pharmacy accreditation, and how hybrid models can deliver both comprehensive oversight and meaningful risk reduction.
Related Concept Videos
Drug Regulation
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Clinically Relevant Drug Product Specifications: Methods of Establishment
Drug Control Governance: Regulatory Bodies and Their Impact
FDA Approved Drugs: Changes to Approved Drugs
Pharmaceutical Poisoning: Potential Scenarios
